sulotroban has been researched along with methylmercuric chloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endele, R; Kaufmann, B; Neugebauer, G; Patscheke, H; Staiger, C; Stegmeier, K; Strein, K | 1 |
| Patscheke, H | 1 |
2 other study(ies) available for sulotroban and methylmercuric chloride
| Article | Year |
|---|---|
Single dose pharmacokinetics and effects on platelet function of the thromboxane receptor blocker BM 13.177.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Blood Platelets; Fibrinolytic Agents; Humans; Kinetics; Male; Methylmercury Compounds; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Serotonin; Sulfonamides; Time Factors | 1986 |
Thromboxane synthase inhibition potentiates washed platelet activation by endogenous and exogenous arachidonic acid.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Collagen; Drug Interactions; Humans; Hydrogen Peroxide; Imidazoles; In Vitro Techniques; Indomethacin; Methylmercury Compounds; Oxidoreductases; Platelet Aggregation; Serotonin; Serum Albumin; Sulfonamides; Thromboxane B2; Thromboxane-A Synthase | 1985 |